Future Financial Focus

InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…

Business

Politics

Investing

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

Stock

Categories

Latest

5 Best-performing Canadian Pharma Stocks of 2025

Piche Resources

Ethereum Price History: A Decade of Disrupting Finance

Union Pacific to buy Norfolk in $85 billion mega U.S. railroad deal

Sranan Gold

Barrick Backs Hercules in Leviathan-Linked Copper Expansion

CHARBONE presentera a la conference Hydrogen East et annonce le developpement d’un hub d’approvisionnement dans le marche de l’Atlantique via sa filiale

Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71% Ni, 0.56% Cu Including 6.1 Metres of 1.17% Ni, 1.45% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario

LaFleur Minerals Inc.Taking Key Steps to Advance Position in Prolific Gold Belt